In the March 31, 2020 COVID-19 interim final rule with comment period (IFC) (85 FR 19241), we stated that we did not believe the frequency limitations for certain subsequent inpatient visits, subsequent NF visits, and critical care consultations furnished via Medicare telehealth were appropriate or necessary for the duration of the PHE because this would have been a patient population who would have otherwise not had access to clinically appropriate in-person treatment
Response: We are finalizing the proposal to establish a repository to receive voluntary submissions from covered entities of certain data elements from Part D 340B claims to allow us to assess such data for use in identifying units of Part D rebatable drugs for which a manufacturer provides a discount under the 340B Program in a future applicable period
However, we did not propose to revise our subgroups' burden estimates because we are operationalizing previously finalized policies that will not impact the utilization of subgroups by groups and hence, will not change the way groups choose to organize clinicians in subgroups
Frequently Asked Questions How much B12 should I take while using semaglutide injections
Multiple board-certified providers confirm that dermaplaning is safe during pregnancy because it involves no chemicals, generates no heat, and removes only dead cells that the body naturally sheds